Mallinckrodt Pharmaceuticals' mission is "Managing Complexity, Improving Lives." This focus is highly evident in our Science and Technology (S&T) organization, comprised of Research and Development (R&D), Medical Affairs, Pharmacovigilance & Drug Safety, Regulatory Affairs, Health Economics & Outcomes Research (HEOR), Development Operations and Programs Management.
We attract highly skilled scientists, clinicians, and other professionals who are experienced and adept at managing the complex pharmaceutical environments we work in every day, and their commitment to finding solutions for the unmet needs of patients is unparalleled.
To continually make steps toward a healthier future, our S&T team is focused on expanding the Mallinckrodt Pharmaceuticals portfolio to address unmet medical needs.
R&D remains a key focal point for our growth moving forward. With more than 14 U.S Food and Drug Administration-approved drugs since 2010 and another two dozen products in the works, Mallinckrodt is committed to developing products that improve patients' lives. See what we've been working on.
Medical Affairs contributes to defining the optimal role of our medicines in the treatment of various conditions and diseases. See ongoing activities.